Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DR26F4B8R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,313
Award facts
- Contract value 100% obligated
- $11,313.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL auto-injector pens valued at $11,313.29 under a firm fixed-price contract. This non-set-aside delivery order, awarded on November 17, 2025, represents a single pharmaceutical procurement with an ultimate completion date of November 18, 2025. The award was made to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations.
This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a comprehensive global pharmaceutical support vehicle, the parent IDC enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs. Dupixent, a biologic immunosuppressant medication used primarily for treating eczema, asthma, and other inflammatory conditions, fulfills critical medical supply needs for Defense Health Agency beneficiaries and other federal healthcare systems. AmerisourceBergen's selection as a pharmaceutical prime vendor underscores its established capability to meet federal procurement requirements through open competition and deliver specialized branded medications to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F4B8R?
SPE2DR26F4B8R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F4B8R worth?
The government has obligated $11,313 on SPE2DR26F4B8R.
Is contract SPE2DR26F4B8R an order under another contract?
Yes. SPE2DR26F4B8R is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4B8R competed?
The extent of competition for SPE2DR26F4B8R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award